01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Open Orphan tip of the year update on mega contract win March 6, 2020 – Posted in: Open Orphan (ORPH)

by Tom Winnifrith Open Orphan (ORPH) was one of my tips of the year at a 4.6p offer. The shares are now 5.5p bid – the recent market sell off hitting it like nearly all other stocks. But the news today of a contract potentially worth £10 million plus really does slam home the message of how cheap the shares are. There are currently no broker forecasts out there but that is something that I…

Continue reading

Open Orphan #ORPH – Appointment of new Director – Posted in: Open Orphan (ORPH)

Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , is pleased to announce, further to its announcement of 13 February 2020, the appointment to the board of Leo Toole as Chief Financial Officer. Leo Toole brings over 20 years’ experience in senior finance roles in Pharmaceuticals, Medical Technology and FMCG sectors. He…

Continue reading

Open Orphan #ORPH – Appointment of Group Chief Financial Officer February 13, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce the appointment of Leo Toole to the role of Group Chief Financial Officer with immediate effect. Leo was previously Interim Chief Financial…

Continue reading

Open Orphan #ORPH presents at Shares Growth and Invention Forum, London February 7, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that the Company will be attending and presenting at the Shares Growth and Invention Forum on February 11, 2020 at Business Design Centre, London N1, London, N1 0QH. Cathal will be presenting at 15:30 in the Babbage Room. Investors are able to register to attend…

Continue reading